BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
4.060
+0.030 (0.74%)
At close: Apr 28, 2026, 4:00 PM EDT
3.990
-0.070 (-1.72%)
After-hours: Apr 28, 2026, 6:55 PM EDT
BriaCell Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is August - July.
Millions USD. Fiscal year is Aug - Jul.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
| Market Capitalization | 29 | 13 | 14 | 106 | 101 | 79 | |
| Market Cap Growth | 96.39% | -6.05% | -87.19% | 4.90% | 29.07% | 1427.04% | |
| Enterprise Value | -1 | -0 | 12 | 77 | 57 | 59 | |
| Last Close Price | 4.06 | 7.46 | 112.87 | 1003.50 | 975.00 | 762.00 | |
| PB Ratio | 0.97 | 0.74 | -5.08 | -28.18 | 9.82 | 2.84 | |
| P/TBV Ratio | 0.95 | 0.72 | - | - | 10.05 | 2.87 | |
| Debt / Equity Ratio | - | - | - | - | - | 0.00 | |
| Net Debt / Equity Ratio | -0.99 | -1.03 | 0.32 | 5.63 | -3.97 | -2.07 | |
| Net Debt / EBITDA Ratio | 0.98 | 0.66 | 0.03 | 0.91 | 2.69 | 8.22 | |
| Net Debt / FCF Ratio | 0.97 | 0.63 | 0.04 | 0.90 | 3.29 | 7.39 | |
| Quick Ratio | 9.39 | 4.49 | 0.21 | 11.80 | 43.64 | 102.88 | |
| Current Ratio | 10.10 | 5.01 | 0.49 | 14.96 | 45.00 | 103.81 | |
| Return on Equity (ROE) | -179.21% | -362.56% | - | -619.75% | -141.25% | -114.78% | |
| Return on Assets (ROA) | -89.44% | -123.56% | -126.11% | -41.71% | -18.99% | -14.89% | |
| Return on Capital Employed (ROCE) | -101.10% | -153.90% | 2097.70% | -91.80% | -36.70% | -12.10% | |
| Earnings Yield | -101.28% | -205.42% | -35.14% | -19.08% | -26.45% | -17.58% | |
| FCF Yield | -105.83% | -219.93% | -180.31% | -22.31% | -12.30% | -9.86% | |
| Buyback Yield / Dilution | -784.70% | -285.70% | -5.35% | -0.81% | -242.82% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.